These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK. Guest JF; Davie AM; Clegg JP Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881 [TBL] [Abstract][Full Text] [Related]
6. [Intermittent claudication: review of a disease of growing prevalence. II. Treatment]. Riambau V; Piñol C Med Clin (Barc); 1998 Feb; 110(6):220-7. PubMed ID: 9580403 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of intermittent claudication. Doggrell SA Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312 [TBL] [Abstract][Full Text] [Related]
8. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638). Roset PN Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374 [No Abstract] [Full Text] [Related]
9. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication. Lee TM; Su SF; Tsai CH; Lee YT; Wang SS Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of cilostazol and other therapies for intermittent claudication. Dawson DL Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896 [TBL] [Abstract][Full Text] [Related]
11. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638). Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373 [No Abstract] [Full Text] [Related]
12. Current and future drug therapies for claudication. Hiatt WR Vasc Med; 1997; 2(3):257-62. PubMed ID: 9546977 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of iloprost in patients with intermittent claudication. Creager MA; Pande RL; Hiatt WR Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433 [TBL] [Abstract][Full Text] [Related]
14. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease. Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195 [TBL] [Abstract][Full Text] [Related]
16. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication? Weismantel D J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570 [No Abstract] [Full Text] [Related]
17. Cilostazol: treatment of intermittent claudication. Reilly MP; Mohler ER Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586 [TBL] [Abstract][Full Text] [Related]
18. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Girolami B; Bernardi E; Prins MH; Ten Cate JW; Hettiarachchi R; Prandoni P; Girolami A; Büller HR Arch Intern Med; 1999 Feb; 159(4):337-45. PubMed ID: 10030306 [TBL] [Abstract][Full Text] [Related]
19. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks. Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717 [TBL] [Abstract][Full Text] [Related]